PE20061117A1 - DERIVADOS DE FENILGLICINAMIDA COMO INHIBIDORES DEL FACTOR VIIa - Google Patents
DERIVADOS DE FENILGLICINAMIDA COMO INHIBIDORES DEL FACTOR VIIaInfo
- Publication number
- PE20061117A1 PE20061117A1 PE2006000049A PE2006000049A PE20061117A1 PE 20061117 A1 PE20061117 A1 PE 20061117A1 PE 2006000049 A PE2006000049 A PE 2006000049A PE 2006000049 A PE2006000049 A PE 2006000049A PE 20061117 A1 PE20061117 A1 PE 20061117A1
- Authority
- PE
- Peru
- Prior art keywords
- alkyl
- inhibitors
- factor viia
- preferred
- phenylglycinamide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/14—Nitrogen atoms not forming part of a nitro radical
Abstract
SE REFIERE A UN COMPUESTO DE FORMULA I DONDE Y ES A, B, ENTRE OTROS; R1 ES H, F, Cl, ALQUILO C1-C5, ENTRE OTROS; R2 Y R3 SON CADA UNO H, F, Cl, OCF3, CN, ENTRE OTROS; R4 ES H, F, CN, NO2, ALQUILO C1-C6, ENTRE OTROS; W ES NH, O; Z ES DE PREFERENCIA 1-ISOQUINOLIN; A ES UN HETEROCICLO DE 4-8 MIEMBROS, DE PREFERENCIA N-PIRROLIDIN; R8 ES H, CN, TETRAZOLILO, ALQUILO C1-C4 SUSTITUIDO; R9 ES FENILACETAMIDA, 2-ISOPROPILTIOFENIL, 3-NITROFENIL, ENTRE OTROS. SON COMPUESTOS PREFERIDOS: SAL ACIDO TRIFLUOROACETICO DE 2-(1-AMINOSIOQUINOLIN-6-ILAMINO)-2-(3-ETOXI-4-ISOPROPOXIFENIL)-1-(2-FENILPIRROLIDIN-1-IL)ETANONA; SAL ACIDO TRIFLUOROACETICO DE N-(3-((S)-1-((R)-2-(1-AMINOISOQUINOLIN-6-ILAMINO)-2-(3-ETOXI-4-ISOPROPOXIFENIL)ACETIL)PIRROLIDIN-2-IL)FENIL)ACETAMIDA; ENTRE OTROS. DICHOS COMPUESTOS SON INHIBIDORES DE LA SERINA PROTEASA DE LA CASCADA DE COAGULACION, EN PARTICULAR DEL FACTOR VIIa UTILES EN EL TRATAMIENTO DE TRASTORNOS TROMBOEMBOLICOS
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US64275105P | 2005-01-10 | 2005-01-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20061117A1 true PE20061117A1 (es) | 2006-10-13 |
Family
ID=36587246
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2006000049A PE20061117A1 (es) | 2005-01-10 | 2006-01-09 | DERIVADOS DE FENILGLICINAMIDA COMO INHIBIDORES DEL FACTOR VIIa |
Country Status (9)
Country | Link |
---|---|
US (1) | US7622585B2 (es) |
EP (1) | EP1856096B1 (es) |
AR (1) | AR054321A1 (es) |
AT (1) | ATE479676T1 (es) |
DE (1) | DE602006016566D1 (es) |
ES (1) | ES2349428T3 (es) |
PE (1) | PE20061117A1 (es) |
TW (1) | TW200637843A (es) |
WO (1) | WO2006076246A2 (es) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE405553T1 (de) * | 2004-12-08 | 2008-09-15 | Bristol Myers Squibb Co | Heterocyclische verbindungen als inhibitoren von faktor viia |
ATE455103T1 (de) * | 2005-06-24 | 2010-01-15 | Bristol Myers Squibb Co | Als antikoagulationsmittel geeignete phenylglycinamid- und pyridylglycinamidderivate |
AR058380A1 (es) * | 2005-12-23 | 2008-01-30 | Bristol Myers Squibb Co | Inhibidores del factor viia macrociclicos utiles como anticoagulantes |
US20070161670A1 (en) * | 2006-01-09 | 2007-07-12 | Bristol-Myers Squibb Company | Process for the preparation of substituted heterocycles |
CN101500993A (zh) | 2006-06-08 | 2009-08-05 | 百时美施贵宝公司 | 作为凝血因子Ⅶa抑制剂用作抗凝血药的2-氨基羰基苯基氨基-2-苯基乙酰胺 |
PE20081775A1 (es) * | 2006-12-20 | 2008-12-18 | Bristol Myers Squibb Co | Compuestos macrociclicos como inhibidores del factor viia |
US8039506B2 (en) * | 2006-12-20 | 2011-10-18 | Bristol-Myers Squibb Company | Bicyclic lactam factor VIIa inhibitors useful as anticoagulants |
GB2467670B (en) * | 2007-10-04 | 2012-08-01 | Intellikine Inc | Chemical entities and therapeutic uses thereof |
WO2009114870A2 (en) | 2008-03-14 | 2009-09-17 | Intellikine, Inc. | Kinase inhibitors and methods of use |
US8993580B2 (en) * | 2008-03-14 | 2015-03-31 | Intellikine Llc | Benzothiazole kinase inhibitors and methods of use |
CA2730106A1 (en) | 2008-07-08 | 2010-01-14 | Intellikine, Inc. | Kinase inhibitors and methods of use |
EP2149565A1 (de) | 2008-07-24 | 2010-02-03 | Bayer Schering Pharma AG | Sulfonsubstituierte Chinazolinderivate als Immunmodulatoren zur Behandlung von enzündlichen und allergischen Erkrankungen |
JP5417860B2 (ja) * | 2008-08-26 | 2014-02-19 | 住友化学株式会社 | α−ヒドロキシエステル類の製造方法 |
US8476431B2 (en) * | 2008-11-03 | 2013-07-02 | Itellikine LLC | Benzoxazole kinase inhibitors and methods of use |
MX337662B (es) | 2010-10-06 | 2016-03-14 | Glaxosmithkline Llc | Derivados de bencimidazol como inhibidores de cinasa pi3. |
TWI592411B (zh) | 2011-02-23 | 2017-07-21 | 英特爾立秦有限責任公司 | 激酶抑制劑之組合及其用途 |
WO2015123091A1 (en) | 2014-02-11 | 2015-08-20 | Merck Sharp & Dohme Corp. | Factor xia inhibitors |
EP3104703B1 (en) | 2014-02-11 | 2020-11-18 | Merck Sharp & Dohme Corp. | Factor xia inhibitors |
EP3134408B1 (en) | 2014-04-22 | 2020-08-12 | Merck Sharp & Dohme Corp. | FACTOR XIa INHIBITORS |
US9868727B2 (en) | 2014-07-28 | 2018-01-16 | Merck Sharp & Dohme Corp. | Factor XIa inhibitors |
WO2017074833A1 (en) | 2015-10-29 | 2017-05-04 | Merck Sharp & Dohme Corp. | Macrocyclic spirocarbamate derivatives as factor xia inhibitors, pharmaceutically acceptable compositions and their use |
BR112018008506B8 (pt) | 2015-10-29 | 2023-12-05 | Merck Sharp & Dohme | Compostos inibidores do fator xia, composição farmacêutica e usos dos mesmos |
WO2017158147A1 (en) | 2016-03-18 | 2017-09-21 | Savira Pharmaceuticals Gmbh | Pyrimidone derivatives and their use in the treatment, amelioration or prevention of a viral disease |
EP3500556B1 (en) | 2016-08-22 | 2023-08-02 | Merck Sharp & Dohme LLC | Pyridine-1-oxide derivatives and their use as factor xia inhibitors |
CN112225647A (zh) * | 2020-10-14 | 2021-01-15 | 河南中医药大学 | 一种合成5-溴-2-甲氧基苯酚的方法 |
Family Cites Families (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5023236A (en) * | 1988-04-07 | 1991-06-11 | Corvas, Inc. | Factor VII/VIIA active site inhibitors |
FR2667864B2 (fr) * | 1990-03-07 | 1994-08-05 | Rhone Poulenc Sante | Derives de n-phenyl glycinamides, leur preparation et les medicaments les contenant. |
US5843442A (en) * | 1990-10-22 | 1998-12-01 | Corvas International, Inc. | Blood coagulation protein antagonists and uses therefor |
US5563127A (en) | 1993-03-24 | 1996-10-08 | The Dupont Merck Pharmaceutical Company | Boronic acid and ester inhibitors of thrombin |
US5602101A (en) * | 1994-03-04 | 1997-02-11 | Eli Lilly And Company | Antithrombotic agents |
US5866542A (en) * | 1994-10-18 | 1999-02-02 | Corvas International, Inc. | Nematode-extracted anticoagulant protein |
AU6944696A (en) | 1995-09-14 | 1997-04-01 | Shionogi & Co., Ltd. | Novel phenylacetic acid derivatives and medicinal composition containing the same |
IL123986A (en) * | 1997-04-24 | 2011-10-31 | Organon Nv | Medicinal compounds |
SI0921116T1 (en) * | 1997-12-04 | 2003-10-31 | F. Hoffmann - La Roche Ag | N-(4-carbamimido-phenyl)-glycine amide derivatives |
US6358960B1 (en) * | 1998-02-17 | 2002-03-19 | Ono Pharmaceutical Co., Ltd. | Amidino derivatives and drugs containing the same as the active ingredient |
US6335324B1 (en) * | 1998-06-25 | 2002-01-01 | Bristol-Myers Squibb Co. | Beta lactam compounds and their use as inhibitors of tryptase |
TR200101744T2 (tr) * | 1998-12-14 | 2001-12-21 | F. Hoffmann-La Roche Ag | Fenilglisin türevleri. |
HUP0105077A3 (en) * | 1999-01-13 | 2005-04-28 | Genentech Inc | Serine protease inhibitors and pharmaceutical compositions containing them |
WO2001044172A1 (en) | 1999-12-15 | 2001-06-21 | Axys Pharmaceuticals, Inc. | Salicylamides as serine protease and factor xa inhibitors |
EP1254901A4 (en) * | 2000-01-26 | 2003-03-05 | Ono Pharmaceutical Co | 5-CHAIN CYCLIC COMPOUNDS, CONTAINING NITROGEN, AND MEDICINAL PRODUCTS CONTAINING THE SAME AS ACTIVE INGREDIENTS |
US6548694B2 (en) | 2000-05-23 | 2003-04-15 | Hoffman-La Roche Inc. | N-(4-carbamimidoyl-phenyl)-glycine derivatives |
DE10027025A1 (de) * | 2000-05-31 | 2001-12-06 | Merck Patent Gmbh | Clycinamide |
WO2002009688A1 (en) | 2000-08-02 | 2002-02-07 | Smithkline Beecham Corporation | Fatty acid synthase inhibitors |
AU1339302A (en) | 2000-10-20 | 2002-05-06 | Biocryst Pharm Inc | Biaryl compounds as serine protease inhibitors |
AU2002227269A1 (en) * | 2000-11-07 | 2002-06-03 | Bristol-Myers Squibb Company | Acid derivatives useful as serine protease inhibitors |
PT1383731E (pt) * | 2001-04-06 | 2009-11-03 | Biocryst Pharm Inc | Compostos de biarilo como inibidores de serina-protease |
DE10139060A1 (de) | 2001-08-08 | 2003-02-20 | Merck Patent Gmbh | Phenylderivate |
US6642386B2 (en) | 2002-02-06 | 2003-11-04 | Hoffmann-La Roche Inc. | N-(4-carbamimidoyl-phenyl)-glycine derivatives |
DE10214832A1 (de) | 2002-04-04 | 2003-10-16 | Merck Patent Gmbh | Phenylderivate 4 |
WO2004072101A2 (en) | 2003-02-11 | 2004-08-26 | Bristol-Myers Squibb Company | Phenylglycine derivatives useful as serine protease inhibitors |
EP1594845A4 (en) * | 2003-02-11 | 2008-05-21 | Bristol Myers Squibb Co | BENZENE ACETAMIDE COMPOUNDS USEFUL AS SERINE PROTEASE INHIBITORS |
DE10310278A1 (de) | 2003-03-10 | 2004-09-23 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue aromatische Bicyclen, deren Herstellung und deren Verwendung als Arzneimittel |
US20050107409A1 (en) * | 2003-03-10 | 2005-05-19 | Boehringer Ingelheim International Gmbh | Aromatic bicyclic compounds, preparation thereof and their use as pharmaceutical compositions |
US7309708B2 (en) | 2003-11-20 | 2007-12-18 | Birstol-Myers Squibb Company | Hepatitis C virus inhibitors |
ATE405553T1 (de) | 2004-12-08 | 2008-09-15 | Bristol Myers Squibb Co | Heterocyclische verbindungen als inhibitoren von faktor viia |
ATE455103T1 (de) | 2005-06-24 | 2010-01-15 | Bristol Myers Squibb Co | Als antikoagulationsmittel geeignete phenylglycinamid- und pyridylglycinamidderivate |
-
2006
- 2006-01-09 ES ES06717735T patent/ES2349428T3/es active Active
- 2006-01-09 DE DE602006016566T patent/DE602006016566D1/de active Active
- 2006-01-09 AR ARP060100077A patent/AR054321A1/es unknown
- 2006-01-09 EP EP06717735A patent/EP1856096B1/en not_active Not-in-force
- 2006-01-09 PE PE2006000049A patent/PE20061117A1/es not_active Application Discontinuation
- 2006-01-09 US US11/328,479 patent/US7622585B2/en active Active
- 2006-01-09 WO PCT/US2006/000571 patent/WO2006076246A2/en active Application Filing
- 2006-01-09 AT AT06717735T patent/ATE479676T1/de not_active IP Right Cessation
- 2006-01-09 TW TW095100708A patent/TW200637843A/zh unknown
Also Published As
Publication number | Publication date |
---|---|
US20060166997A1 (en) | 2006-07-27 |
AR054321A1 (es) | 2007-06-20 |
TW200637843A (en) | 2006-11-01 |
ATE479676T1 (de) | 2010-09-15 |
WO2006076246A2 (en) | 2006-07-20 |
ES2349428T3 (es) | 2011-01-03 |
DE602006016566D1 (de) | 2010-10-14 |
US7622585B2 (en) | 2009-11-24 |
EP1856096B1 (en) | 2010-09-01 |
WO2006076246A3 (en) | 2006-09-28 |
EP1856096A2 (en) | 2007-11-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20061117A1 (es) | DERIVADOS DE FENILGLICINAMIDA COMO INHIBIDORES DEL FACTOR VIIa | |
PE20090601A1 (es) | Derivados de piridin-il-oxi-piridinas como inhibidores de alk5 | |
PE20081385A1 (es) | Derivados de nicotinamida | |
PE20090434A1 (es) | Derivados de sulfonil amida como inhibidores de quinasas | |
PE20090509A1 (es) | El uso de derivados de benzamida para el tratamiento de transtornos del snc | |
PE20110150A1 (es) | Amidofenoxiindazoles como inhibidores de c-met | |
PE20070218A1 (es) | COMPUESTOS DE CICLOALQUILO AMINO-HIDANTOINA Y USO DE ESTOS PARA LA MODULACION DE ß-SECRETASA | |
PE20070189A1 (es) | COMPUESTO DE AMINO-5-HETEROARILO (5 MIEMBROS) IMIDAZOLONA Y SU USO PARA MODULACION DE LA ß-SECRETASA | |
AR050941A1 (es) | SERINAMIDAS SUSTITUIDAS POR BENZOILO, PROCESOS PARA SU PREPARACION, INTERMEDIARIOS PARA SU SINTESIS, USO DE LAS MISMAS EN LA FABRICACIoN DE PRODUCTOS FITOSANITARIOS Y PROCEDIMEITNSO PARA CONTROLAR EL CRECIMIENTO DE PLANTAS INDESEADAS | |
AR078944A1 (es) | Inhibidores de n1-pirazoloespirocetona acetil-coa carboxilasa | |
PE20091201A1 (es) | AMIDAS SUSTITUIDAS COMO INHIBIDORES DE LA TIROSINA QUINASA DE BRUTON (Btk) | |
PE20121157A1 (es) | Compuestos heterociclicos como inhibidores de proteasas serinas | |
PE20070593A1 (es) | Compuestos pirrolopirimidina como inhibidores de syk | |
PE20071132A1 (es) | Compuestos macrociclicos como inhibidores del factor viia | |
PE20061198A1 (es) | Derivados de pirazol como inhibidores de cdk y gsk | |
PE20080906A1 (es) | Derivados heteroarilo como inhibidores de citocina | |
PE20080856A1 (es) | Inhibidores de metaloproteasas de matriz | |
EA201170130A1 (ru) | Бензоксазины, бензотиазины и родственные соединения, обладающие ингибирующей nos активностью | |
PE20060241A1 (es) | 2-quinolil-oxazoles sustituidos como inhibidores de pde4 | |
CO6170361A2 (es) | Composiciones y metodos para modular receptores de c-kit y pdgfr | |
PE20080061A1 (es) | Compuestos derivados de amida como inhibidores de los canales de potasio task-1 y task-3 | |
PE20050691A1 (es) | Proceso para preparar carboxamidas 2-aminotiazol-5-aromaticas como inhibidores de la cinasa | |
PE20120229A1 (es) | Compuestos heterociclicos como inhibidores de proteasa aspartica | |
PE20090606A1 (es) | Nuevos inhibidores de catepsina c y uso | |
NO20091553L (no) | Fenylderivater og deres anvendelse som immunmodulatorer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Refusal |